An estimated 18 million Americans – 7% of the country’s adults – can’t afford the medicine they need. And 1 in 10 admitted to skipping prescribed doses to make their medicine last longer. These statistics from mid-2021 aren’t improving. They paint a shocking portrait of the pharmaceutical situation.
Unsurprisingly then, reducing medical costs is one of the hottest topics in the country. When President Biden came to power, reducing health insurance and drug costs were the top two priorities citizens had for him.
Though not a politician, Mark Cuban’s new drug company is aiming to achieve the latter of those goals.